Skip to content

Starvation in the Treatment of Diabetic Ketoacidosis

Starvation in the Treatment of Diabetic Ketoacidosis: Is There Enough Evidence to Support This Practice?

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06186245
Enrollment
93
Registered
2023-12-29
Start date
2023-12-27
Completion date
2025-12-31
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Diabetic Ketoacidosis

Brief summary

Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are common, but serious metabolic disorders are often encountered in intensive care. In the intensive care setting, it is common to withhold food from patients during treatment of DKA. However, there is no evidence or current literature supporting this practice. The following proposed research investigates the initiation of an early diet versus withholding food during the treatment of diabetic ketoacidosis.

Interventions

OTHEREarly feeding with an oral diet

Participants in the treatment arm will be initiated on a clear liquid diet on day 1 of medical ICU admission. Diet will be progressed on day 2 to full liquid diet or diabetic diet as patient tolerates based on which diet the patient would prefer.

Sponsors

Texas Tech University Health Sciences Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
Yes

Inclusion criteria

* Males and females with the diagnosis of diabetic ketoacidosis (defined as blood glucose greater than 250 mg/dL, arterial pH less than 7.3, serum bicarbonate less than 15 mEq/L, and the presence of ketonemia or ketonuria) * Age between 18-89 * Admission to the Medical Intensive Care Unit * Able to provide informed consent

Exclusion criteria

* Pregnant and breast-feeding women * Institutionalized patients or prisoners * Patients unable to eat by mouth, including intubation, presence of any tube used for enteral feeding (nasogastric tube, orogastric tube, PEG tube, etc.), medical conditions requiring parenteral feeding, and a history of a medical condition that prevented oral intake prior to admission, including achalasia, esophageal cancer, stroke with residual deficits preventing oral intake, amyotrophic lateral sclerosis, or head and neck trauma.

Design outcomes

Primary

MeasureTime frameDescription
Resolution of DKATypically resolution of DKA is 24-72 hours, may be up to 5 days in some patientsDefined as a closed anion gap. Adjusted Anion Gap defined as (Blood Sodium - Blood Chloride - Blood Bicarbonate) + 0.25 x ((normal albumin (4.0)) x (observed albumin)); Elevated Anion Gap is \>12
Length of stay in the medical intensive care unit (in days).Days (Typically 3-5 days in the MICU, may be up to 1 week).The time from admission order is placed to the time the transfer to another unit order is placed

Secondary

MeasureTime frameDescription
Length of stay in the hospital3-7 days, may be up to 1-2 weeks.from admission order time to the discharge order time
mortality30 dayIf patient passes away within 30 days of participating in the study

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKenneth Kenneth, MD

Texas Tech University Health Sciences Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026